Clinical Significance of Urinary Liver-Type Fatty Acid–Binding Protein in Patients With Diabetic Nephropathy
- 1 August 2005
- journal article
- Published by American Diabetes Association in Diabetes Care
- Vol. 28 (8) , 2038-2039
- https://doi.org/10.2337/diacare.28.8.2038
Abstract
Adult patients with type 2 diabetes were recruited from the outpatient clinic of the Division of Nephrology and Hypertension, Diabetes Center, Tokyo Women’s Medical University Hospital, Tokyo, Japan. Patients were classified into four stages of nephropathy according to albumin-to-creatinine ratio (ACR) in the first-morning urine and serum creatinine concentrations. Patients with a serum creatinine concentration ≥2.0 mg/dl were categorized as having renal failure. Patients with serum creatinine <2.0 mg/dl were classified as normoalbuminuric if ACR was <30 mg/g creatinine, as microalbuminuric if ACR was 30–299 mg/g creatinine, and as having clinical albuminuria if ACR was ≥300 mg/g creatinine (6).Keywords
This publication has 6 references indexed in Scilit:
- Urinary Excretion of Fatty Acid-Binding Protein Reflects Stress Overload on the Proximal TubulesThe American Journal of Pathology, 2004
- Urinary fatty acid–binding protein as a new clinical marker of the progression of chronic renal diseaseJournal of Laboratory and Clinical Medicine, 2004
- Nephropathy in DiabetesDiabetes Care, 2004
- A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction EquationAnnals of Internal Medicine, 1999
- Tubulointerstitial Changes as a Major Determinant in the Progression of Renal DamageAmerican Journal of Kidney Diseases, 1992
- Two types of fatty acid-binding protein in human kidney. Isolation, characterization and localizationBiochemical Journal, 1991